Organization Profile

Related Organization(s)

You just read:

Lexicon and Ipsen Expand Their Licensing and Commercialization Agreement for Telotristat Etiprate to Include Canada

News provided by

Lexicon Pharmaceuticals, Inc.

Mar 18, 2015, 08:30 ET